Uri S. Soiberman, M.D. joined Wilmer's Cornea faculty in 2016, and is an associate professor of ophthalmology and the director of the cornea fellowship at the Wilmer Eye Institute. Dr. Soiberman's main clinical and research focus is keratoconus, and his research has been funded by the National Eye Institute and Research to Prevent Blindness. Dr. Soiberman offers his keratoconus patients advanced surgical treatments, including corneal collagen crosslinking, deep anterior lamellar keratoplasty and other types of corneal transplants for keratoconus. Dr. Soiberman also performs endothelial keratoplasty (DSEK, DMEK, DSO) for patients with Fuchs endothelial dystrophy and corneal edema. In addition, Dr. Soiberman specializes in complex cataract surgery, and offers his patients specialty intraocular lenses (such as astigmatism correcting or multifocal lenses). His surgical acumen includes surgery for dislocated lenses and secondary implantation of intraocular lenses. Dr. Soiberman is highly rated in 5 conditions, according to our data. His top areas of expertise are Keratoconus, Cataract, Interstitial Keratitis, Corneal Transplant, and Vitrectomy.

Mandeep S. Singh, M.D., Ph.D., is associate professor of ophthalmology and genetic medicine in the Retina Division of the Wilmer Eye Institute and the recipient of the 2023 Andreas C. Dracopoulos Professorship in Ophthalmology. Dr. Singh is a retinal specialist. He is Co-Director of the Genetic Eye Disease (GEDi) Center, and is a principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM). Dr. Singh completed his medical degree at the National University of Singapore. In 2009, he was elected to the Fellow of the Royal College of Surgeons of Edinburgh. He earned a PhD in ophthalmology from the University of Oxford, United Kingdom, in 2014. He completed fellowships in vitreoretinal diseases and surgery at the Oxford Eye Hospital and Moorfields Eye Hospital, both in the United Kingdom. His clinical expertise includes surgical, medical and genetic conditions of the retina and macula. Dr. Singh is specialty-trained in vitrectomy surgery for retinal detachment, macular holes, macular pucker, epiretinal membrane, proliferative vitreoretinopathy, complex retinal detachments including reoperations, vitreous hemorrhage removal, and other retinal surgeries. He also specializes in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. Dr. Singh sees patients and families with genetic retinal diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and macular dystrophies. His research focus is retinal stem cell transplantation. Dr. Singh’s work has been recognized through the Eye Institute–Allergan Research Prize, the Merton College University of Oxford Graduate Prize Scholarship, the Oxford Ophthalmological Congress Founder’s Cup and Medal, the Ruskell Medal, the Johns Hopkins Clinician Scientist Award, and the Bert M. Glaser, MD Award for Innovative Research in Retina. He is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He is also a member of the Club Jules Gonin and the Macula Society. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Singh_CV.pdf. Dr. Singh is highly rated in 20 conditions, according to our data. His top areas of expertise are Retinitis Pigmentosa, Stargardt Macular Degeneration, Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is highly rated in 18 conditions, according to our data. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Dr. Neil Bressler has been a member of the Wilmer Eye Institute's faculty since 1988 and is the inaugural James P. Gills Professor of Ophthalmology. He specializes in retinal diseases, with special interests in diabetic retinopathy and macular degeneration. Dr. Bressler's main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored almost 300 peer-reviewed publications. He is a past chair of the NIH-sponsored Diabetic Retinopathy Clinical Research Network, and was responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He also has chaired the National Eye Institutes Data and Safety Monitoring Committee for intramural clinical trials and the FDA Ophthalmic Devices Panel. Dr. Bressler is currently editor-in-chief of JAMA Ophthalmology. Dr. Bressler is highly rated in 18 conditions, according to our data. His top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Cataract Removal.

Yannis M. Paulus, M.D., F.A.C.S., is the Jonas Fridenwald Professor in Ophthalmology, an associate professor in the Johns Hopkins University Department of Ophthalmology and Department of Biomedical Engineering, and a vitreoretinal surgeon at the Wilmer Eye Institute, Johns Hopkins Medicine’s East Baltimore and Columbia locations. Dr. Paulus served as a surgical retina specialist and director of a research laboratory at the University of Michigan Kellogg Eye Center for almost 10 years, where he developed novel imaging systems, lasers and long-lasting therapies and nanotechnologies to allow physicians to determine cellular markers of disease, enabling early diagnosis, improved treatment monitoring and more individualized, personalized precision medicine tailored to each patient’s needs. After earning his bachelor’s degree in chemistry and physics from Harvard University and his medical degree at Stanford University School of Medicine, Dr. Paulus completed an internship at the Sloan-Kettering Cancer Center, a residency in ophthalmology at the Stanford University School of Medicine Byers Eye Institute, and a surgical and medical retina fellowship at Wilmer Eye Institute, Johns Hopkins Medicine. CVhttps://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Paulus_CV%2021225.pdf. Dr. Paulus is highly rated in 18 conditions, according to our data. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal.

Jennifer Thorne, M.D., Ph.D., is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, where she is also chief of the Division of Ocular Immunology. Dr. Thorne holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized ophthalmologist, Dr. Thorne is an expert in the evaluation and management of patients with uveitis and other related immune-mediated disorders. Dr. Thorne also directs the Mucous Membrane Pemphigoid clinic, a multi-disciplinary specialty clinic designed to evaluate and treat patients with conjunctival diseases. Dr. Thorne's research interests include white dot syndromes including birdshot chorioretinitis, multifocal choroiditis and punctate inner choroiditis. She also studies juvenile idiopathic arthritis-related uveitis and treatment outcomes of immunosuppressive drug therapy. Dr. Thorne received her M.D. degree from the University of Virginia and completed her ophthalmology residency at the University of Pennsylvania's Scheie Eye Institute. She completed her uveitis fellowship at Wilmer and completed her Ph.D. in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Thorne is highly rated in 17 conditions, according to our data. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, Cataract Removal, and Vitrectomy.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is highly rated in 14 conditions, according to our data. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is highly rated in 14 conditions, according to our data. Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is highly rated in 13 conditions, according to our data. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is highly rated in 10 conditions, according to our data. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is highly rated in 9 conditions, according to our data. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Dr. Pradeep Ramulu is a glaucoma specialist and the director of the Wilmer Eye Institute glaucoma division. He specializes in caring for both routine and complex glaucomas, including glaucomas requiring repeat operations, glaucoma occurring in the context of corneal or retinal disease and glaucoma occurring in newborns and young children. The Sheila K. West Professor of Ophthalmology at the Wilmer Eye Institute, Dr. Ramulu grew up in suburban Chicago, and became interested in the eye during medical school, during which time he studied the genes and proteins of the eye with Dr. Jeremy Nathans. After pursuing a residency in ophthalmology and fellowship training in glaucoma, he joined Wilmer in 2006. Dr. Ramulu is highly rated in 9 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Cataract, Iridectomy, and Cataract Removal.

"Oliver Schein, M.D., M.P.H., is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein's clinical expertise is in medical and surgical conditions of the anterior segment of the eye including cataract and complications of cataract surgery, corneal scarring and corneal surgery. He is a past author of the American Academy of Ophthalmology's ""Preferred Practice Pattern"" on Cataract. Research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment and outcomes research in ophthalmology. Dr. Schein received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University's Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.". Dr. Schein is highly rated in 7 conditions, according to our data. His top areas of expertise are Cataract, Endophthalmitis, Fuchs Dystrophy, Cataract Removal, and Vitrectomy.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is highly rated in 7 conditions, according to our data. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Henry D. Jampel, M.D., M.H.S., is the Odd Fellows Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in glaucoma and serves as the medical director of Wilmer's Green Spring Station location. His research interests include evaluation of medical vs. surgical treatment of glaucoma in newly diagnosed patients and on imaging devices for the detection of glaucoma and its progression. Dr. Jampel received his M.D. degree from Yale University and his M.H.S. in health finance and management from the Johns Hopkins Bloomberg School of Public Health. He completed an internship in internal medicine at Sinai Hospital and his residency in ophthalmology at the Wilmer Eye Institute. After completing a glaucoma fellowship in glaucoma at Wilmer, Dr. Jampel joined the faculty in 1988. Dr. Jampel is highly rated in 6 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Sturge-Weber Syndrome, Trabeculectomy, and Cataract Removal.

David L. Guyton, M.D., is the Zanvyl Krieger Professor of Ophthalmology. He is internationally known for his contributions, inventions, and teaching in the fields of ophthalmic optics, clinical refraction, potential acuity testing, and ocular motility. His clinical practice in strabismus is heavily surgical, both pediatric and adult, with emphasis on re-operations and cyclovertical surgery, using adjustable sutures. With adults comprising more than 80 percent of his strabismus surgical cases, Dr. Guyton has contributed significantly to our knowledge of strabismus complications from local anesthetics, the “inverted Brown pattern,” the “dragged-fovea diplopia syndrome,” theories of how and why strabismus develops in the first place, and how and why it can change over time. Dr. Guyton is currently developing automated instruments for the vision screening of infants and children. Dr. Guyton is highly rated in 5 conditions, according to our data. His top areas of expertise are Strabismus, Brown Syndrome, Amblyopia, and Esotropia.

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is highly rated in 4 conditions, according to our data. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

John D. Gottsch, M.D., is the Margaret C. Mosher Professor of Ophthalmology at the Wilmer Eye Institute. Dr. Gottsch specializes in the management of hereditary corneal disorders such as Fuchs' dystrophy, the surgical treatment of cataract and complications of cataract surgery, and corneal transplantation surgery. His clinical practice involves the medical treatment of allergic eye diseases and severe corneal inflammation from rheumatoid and other related disorders, including Mooren''s ulcer. His research interests include determining the gene expression of the cornea and the genetic basis for hereditary corneal diseases such as Fuchs' dystrophy. Dr. Gottsch is highly rated in 3 conditions, according to our data. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Cataract, and Corneal Transplant.

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is highly rated in 2 conditions, according to our data. Her top areas of expertise are Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.

Olga Shif is an Ophthalmologist in Owings Mills, Maryland. Dr. Shif is highly rated in 21 conditions, according to our data. Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy.

Timothy D. Polk, MD, specializes in comprehensive ophthalmology. He is affiliated with UPMC Memorial. Dr. Polk completed his fellowships at the University of Iowa Hospitals and Clinics and Bascom Palmer Eye Institute, residency at Greater Baltimore Medical Center and medical degree at the University of Virginia School of Medicine. Dr. Polk is highly rated in 16 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, Retinal Vein Occlusion, and Vitrectomy.

Janet Sunness is an Ophthalmologist in Towson, Maryland. Dr. Sunness is highly rated in 16 conditions, according to our data. Her top areas of expertise are Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Rohit Lakhanpal is an Ophthalmologist in Baltimore, Maryland. Dr. Lakhanpal is highly rated in 9 conditions, according to our data. His top areas of expertise are Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy.

Dr. Stephen S. Pappas, Jr. is native to the Washington, D.C. area and has been in medical and surgical retinal practice for over 15 years. He is committed to providing personalized and compassionate retinal care, maintaining expertise and technology to offer the latest retinal treatments, and working closely with each patient’s medical team to preserve and restore vision. Dr. Pappas holds a B.A. from Bucknell University and earned his Medical Degree from George Washington University in 1989. Following his Ophthalmology Residency at the Washington Hospital Center, he pursued and completed his Clinical Fellowship training in Vitreoretinal diseases and surgery at the Retina Institute of Maryland (now known as the National Retina Institute) in Baltimore, MD, where he performed clinical research and participated in landmark clinical trials investigating both medical and surgical retinal treatments. Upon completion of his training in 1995, Dr. Pappas joined his father, one of the first fellowship-trained retina specialists in the Washington, D.C. area, in private group practice in Bethesda. In 2001, Dr. Pappas founded the Center for Retinal Diseases and Surgery, LLC, where he continues the tradition of personalized, compassionate retinal care established by his father nearly 50 years ago. Dr. Pappas is married with two children and resides in Montgomery County where he also serves as a trustee for two non-profit organizations. Recreationally, Dr. Pappas is an avid fan of his children’s sports and enjoys golf, skiing and holds a black belt in Tae Kwon Do. Learn more about Dr. Pappas by visiting his website . Dr. Pappas is highly rated in 9 conditions, according to our data. His top areas of expertise are Blue Cone Monochromatism, Color Blindness, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

Marc Honig is an Ophthalmologist in Owings Mills, Maryland. Dr. Honig is highly rated in 7 conditions, according to our data. His top areas of expertise are Cataract, Chalazion, Eyelid Bump, and Glaucoma.